Showing results (81-90 of 798) with videos related to
Sort By:
Pageof 80
Medchemcomm|August 16, 2018
Aryl-alkyl-lysines: small molecular membrane-active antiplasmodial agentsChandradhish Ghosh, Shweta Chaubey, Utpal Tatu, et al.Medchemcomm|August 16, 2018
Synthesis and biological evaluation of 8-hydroxy-2,7-naphthyridin-2-ium salts as novel inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE)M Schiedel, A Fallarero, C Luise, et al.Medchemcomm|August 16, 2018
Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016)G Carullo, F Galligano, F AielloMedchemcomm|August 16, 2018
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenonesGudikadi Linga Goud, Seela Ramesh, Dongamanti Ashok, et al.Medchemcomm|August 16, 2018
Identification of mitoxantrone as a new inhibitor of ROS1 fusion protein in non-small cell lung cancer cellsLian-Xiang Luo, Xing-Xing Fan, Ying Li, et al.Medchemcomm|August 16, 2018
Chitosan nanoparticles for nitric oxide delivery in human skinM T Pelegrino, R B Weller, X Chen, et al.Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.Medchemcomm|August 16, 2018
Design and synthesis of cenocladamide analogues and their evaluation against breast cancer cell linesCarla C F Santos, Luciana S Paradela, Luiz F T Novaes, et al.Medchemcomm|August 16, 2018
Quantitative measurement of intracellular HDAC1/2 drug occupancy using a trans-cyclooctene largazole thiol probeHua Xu, Lee R Roberts, Song Chou, et al.Medchemcomm|August 16, 2018
The structure-guided discovery of osimertinib: the first U.S. FDA approved mutant selective inhibitor of EGFR T790MSam Butterworth, Darren A E Cross, M Raymond V Finlay, et al.Pageof 80